riluzole has been researched along with Cancer of Pancreas in 3 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Excerpt | Relevance | Reference |
---|---|---|
" Riluzole (RIL) is mainly used to treat amyotrophic lateral sclerosis clinically, but many previous studies have shown that RIL could inhibit tumors." | 4.02 | The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways. ( He, X; Jiang, X; Sun, R; Tao, H, 2021) |
"Riluzole was given at 100 mg PO BID in combination with sorafenib, beginning at 200 mg PO daily and escalating in 200 mg increments per level in 28-day cycles." | 3.30 | A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850. ( Aisner, J; Cerchio, R; Chan, N; Chen, S; Ganesan, S; Goodin, S; Gounder, M; Li, J; Lin, H; Malhotra, J; Marinaro, C; Mehnert, JM; Portal, DE; Shih, W; Silk, AW; Spencer, KR; Stein, MN, 2023) |
"However, pancreatic cancer cells switch to glutamine metabolism to survive under hypoxic conditions." | 1.72 | Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway. ( Lam, BQ; Ma, Y; Roy, SK; Shankar, S; Shrivastava, A; Srivastav, S; Srivastava, RK, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Roy, SK | 1 |
Ma, Y | 1 |
Lam, BQ | 1 |
Shrivastava, A | 1 |
Srivastav, S | 1 |
Shankar, S | 1 |
Srivastava, RK | 1 |
Spencer, KR | 1 |
Portal, DE | 1 |
Aisner, J | 1 |
Stein, MN | 1 |
Malhotra, J | 1 |
Shih, W | 1 |
Chan, N | 1 |
Silk, AW | 1 |
Ganesan, S | 1 |
Goodin, S | 1 |
Gounder, M | 1 |
Lin, H | 1 |
Li, J | 1 |
Cerchio, R | 1 |
Marinaro, C | 1 |
Chen, S | 1 |
Mehnert, JM | 1 |
Sun, R | 1 |
He, X | 1 |
Jiang, X | 1 |
Tao, H | 1 |
1 trial available for riluzole and Cancer of Pancreas
Article | Year |
---|---|
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Maximum Tolerated Dose; Neoplasms; Niacinami | 2023 |
2 other studies available for riluzole and Cancer of Pancreas
Article | Year |
---|---|
Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway.
Topics: Animals; beta Catenin; Cell Line, Tumor; Cell Proliferation; Glutamine; Mice; Pancreatic Neoplasms; | 2022 |
Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway.
Topics: Animals; beta Catenin; Cell Line, Tumor; Cell Proliferation; Glutamine; Mice; Pancreatic Neoplasms; | 2022 |
Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway.
Topics: Animals; beta Catenin; Cell Line, Tumor; Cell Proliferation; Glutamine; Mice; Pancreatic Neoplasms; | 2022 |
Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway.
Topics: Animals; beta Catenin; Cell Line, Tumor; Cell Proliferation; Glutamine; Mice; Pancreatic Neoplasms; | 2022 |
The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways.
Topics: Amyotrophic Lateral Sclerosis; Apoptosis; Autophagy; Cell Line, Tumor; Humans; Pancreatic Neoplasms; | 2021 |
The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways.
Topics: Amyotrophic Lateral Sclerosis; Apoptosis; Autophagy; Cell Line, Tumor; Humans; Pancreatic Neoplasms; | 2021 |
The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways.
Topics: Amyotrophic Lateral Sclerosis; Apoptosis; Autophagy; Cell Line, Tumor; Humans; Pancreatic Neoplasms; | 2021 |
The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways.
Topics: Amyotrophic Lateral Sclerosis; Apoptosis; Autophagy; Cell Line, Tumor; Humans; Pancreatic Neoplasms; | 2021 |